Literature DB >> 15516926

Autoreactivity and allelic inclusion in a B cell nuclear transfer mouse.

Tobias Gerdes1, Matthias Wabl.   

Abstract

Lymphocytes typically express only one functional antigen receptor, a restriction contributed to by allelic exclusion. Here we have analyzed B lymphocyte development in offspring of a mouse generated by nuclear transfer using a single donor B lymphocyte. In this mouse, all immunoglobulin alleles were inherited as found in the donor lymphocyte. This donor cell had two rearranged immunoglobulin light chain alleles, both directing the synthesis of light chains that could form functional antigen receptors, one of which was autoreactive. Progeny mice carrying this immunoglobulin light chain allele produced mature B cells, some of which continued to express the autoreactive receptor but required another rearrangement to rescue them from negative selection. Such receptor editing failed to destroy expression of one original light chain allele, thereby recreating dual receptor expression on these surviving B cells. We suggest that autoreactive antibodies in serum of mice and humans are due in part to such 'passenger' receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516926     DOI: 10.1038/ni1133

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  19 in total

Review 1.  Allelic exclusion of immunoglobulin genes: models and mechanisms.

Authors:  Christian Vettermann; Mark S Schlissel
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

2.  Editing and escape from editing in anti-DNA B cells.

Authors:  Salar N Khan; Esther J Witsch; Noah G Goodman; Anil K Panigrahi; Ching Chen; Yufei Jiang; Amy M Cline; Jan Erikson; Martin Weigert; Eline T Luning Prak; Marko Radic
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-29       Impact factor: 11.205

3.  Pro-B cells sense productive immunoglobulin heavy chain rearrangement irrespective of polypeptide production.

Authors:  Johannes Lutz; Marinus R Heideman; Edith Roth; Paul van den Berk; Werner Müller; Chander Raman; Matthias Wabl; Heinz Jacobs; Hans-Martin Jäck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

Review 4.  Checkpoints that control B cell development.

Authors:  Fritz Melchers
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

5.  Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE.

Authors:  Thiago Detanico; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Autoimmun       Date:  2015-01-26       Impact factor: 7.094

6.  Light chain inclusion permits terminal B cell differentiation and does not necessarily result in autoreactivity.

Authors:  C Sirac; C Carrion; S Duchez; I Comte; M Cogné
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

7.  Role of the Igh intronic enhancer Eμ in clonal selection at the pre-B to immature B cell transition.

Authors:  Cheng Peng; Laurel A Eckhardt
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

8.  Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection.

Authors:  Laurent Verkoczy; Bao Duong; Patrick Skog; Djemel Aït-Azzouzene; Kamal Puri; José Luis Vela; David Nemazee
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

Review 9.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

10.  Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors.

Authors:  Brun Mietzner; Makoto Tsuiji; Johannes Scheid; Klara Velinzon; Thomas Tiller; Klaus Abraham; Jose B Gonzalez; Virginia Pascual; Dorothee Stichweh; Hedda Wardemann; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.